Redeye: Speqta - Attractive Growth Case

Redeye conducts substantial estimate changes and raises base case in Speqta following a value-adding Finnish acquisition and growth-oriented financial targets. In contrast to our positive view, the share has declined 25% in one month and approached our bear case, indicating excessively pessimistic investor expectations.

Read more and download the research update: http://bit.ly/2PZUwWN

Start following companies at Redeye to recieve the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/